Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.84096
+0.19096 (29.38%)
At close: Jul 27, 2026
Cell Source Market Cap
Cell Source has a market cap or net worth of $57.14 million as of July 28, 2026. Its market cap has increased by 189.05% in one year.
Market Cap
57.14M
Enterprise Value
67.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.84
ChartMarket Cap Chart
Since July 1, 2014, Cell Source's market cap has increased from 36.03M to 57.14M, an increase of 58.58%. That is a compound annual growth rate of 3.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 57.14M | 134.08% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 85.98M |
| BioStem Technologies | 71.08M |
| Nuo Therapeutics | 49.38M |
| Vicapsys Life Sciences | 47.26M |
| Arch Biopartners | 41.09M |
| ProText Mobility | 36.92M |
| Sangamo Therapeutics | 26.93M |
| EOM Pharmaceuticals Holdings | 26.41M |